Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation
Daniela Schuster(Trinity College Dublin), Gerhard Wolber(Research Institute for Pharmacy and Biochemistry (Czechia)), Patrick Markt(Universität Innsbruck), Markus Binder(Medical University of Vienna), Stefan M. Noha(Universität Innsbruck), Judit Mihaly‐Bison(Medical University of Vienna), Judith M. Rollinger(University of Vienna), Ulrike Grienke(Universität Innsbruck), Valery N. Bochkov(Medical University of Vienna), Hermann Stuppner(Universität Innsbruck)
Cited by 50
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Discovery and resupply of pharmacologically active plant-derived natural products: A review
|Biotechnology Advances|2015|2.9k
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
|Biochemical Pharmacology|2014|593
Energy/Temperature Diagram and Compression Behavior of the Polymorphs of d-Mannitol
|Journal of Pharmaceutical Sciences|2000|363
Acetylcholinesterase Inhibitory Activity of Scopolin and Scopoletin Discovered by Virtual Screening of Natural Products
|Journal of Medicinal Chemistry|2004|211